hydroxyurea has been researched along with 1-arabinofuranosylcytosine-5'-stearylphosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arkoumani, E; Bourantas, K; Kalambokis, G; Kitsanou, M; Stefanou, D; V Tsianos, E | 1 |
| Chiba, S; Fukayama, M; Goyama, S; Inoue, M; Izutsu, K; Kako, S; Kanda, Y; Kurokawa, M; Motokura, T; Noda, N; Oshima, K; Sato, T; Shoda, E; Watanabe, T | 1 |
2 other study(ies) available for hydroxyurea and 1-arabinofuranosylcytosine-5'-stearylphosphate
| Article | Year |
|---|---|
Fulminant bronchiolitis obliterans organizing pneumonia following 2 d of treatment with hydroxyurea, interferon-alpha and oral cytarabine ocfosfate for chronic myelogenous leukemia.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Cryptogenic Organizing Pneumonia; Cytidine Monophosphate; Fatal Outcome; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Male; Radiography, Thoracic; Tomography, X-Ray Computed | 2004 |
Early relapse of JAK2 V617F-positive chronic neutrophilic leukemia with central nervous system infiltration after unrelated bone marrow transplantation.
Topics: Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleotides; Bone Marrow Transplantation; Brain; Chromosome Inversion; Chromosomes, Human, Pair 9; Combined Modality Therapy; Cytidine Monophosphate; Dysarthria; Fatal Outcome; Humans; Hydroxyurea; Hyperesthesia; Janus Kinase 2; Leukemia, Neutrophilic, Chronic; Leukemic Infiltration; Male; Middle Aged; Neoplasm Proteins; Recurrence; Transplantation, Homologous | 2007 |